In The News
High Court cases could push Blue Sky class action trial to 2026
Google faces potential class action over AdTech dominance
Court approves landmark $75M detention centre class action settlement
Dominique Grubisa’s companies illegally scraped court websites: OAIC
Union may face class action for alleged adverse action on basis of political opinion
Collapsed Mosaic Brands owes creditors over $245M
Travelex wins opposition to blockchain tech company’s trade marks
Class action firm breaches costs disclosure rules again, fights penalty
Court won’t suppress name of barrister accused of sexual harassment
Firm in push for solicitors’ CFO in Philips class action, despite uncertainty
Please login to bookmarkClose

A unit of Purdue Pharma has fired off a cross-claim in Australian drug maker AUPharma’s lawsuit alleging the US drug giant was wrongly granted patent extensions for oxycodone products marketed as Targin.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au